ET
The startup specializes in precision genetic therapies that modulate neural activity to treat various neurological disorders. By utilizing targeted gene editing techniques, it aims to improve patient outcomes in conditions such as epilepsy and neurodegenerative diseases.
Updated 3 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup specializes in precision genetic therapies that modulate neural activity to treat various neurological disorders. By utilizing targeted gene editing techniques, it aims to improve patient outcomes in conditions such as epilepsy and neurodegenerative diseases.